Q1 2027 Veeva Systems Inc Earnings Call Transcript
Key Points
- Veeva Systems Inc (VEEV) reported total revenue of $883 million for the quarter, surpassing their guidance.
- The company introduced Veeva Falcon, a disruptive AI-driven product aimed at automating labor-intensive tasks in drug development.
- Strong performance in the R&D and Quality Cloud segments, with significant growth potential in early-stage products like eCOA and RTSM.
- Crossix continues to show robust growth, driven by increased digital spending in the pharma industry and new innovations.
- The acquisition of Ostro is expected to contribute significantly to commercial subscription revenue, enhancing Veeva's digital engagement capabilities.
- Despite a strong start to the year, Veeva Systems Inc (VEEV) only raised its full-year revenue guidance by $5 million, indicating potential conservatism or unforeseen challenges.
- The transition to AI applications in pharma is complex, and the full integration of AI into existing systems may take time.
- There is a risk of cannibalization of traditional SaaS revenue streams as AI-driven solutions like Falcon become more prevalent.
- The company faces competitive pressure in the CRM space, with ongoing migration decisions among top 20 pharma companies.
- Veeva Systems Inc (VEEV) is making significant investments in AI and other areas, which could impact short-term margins and profitability.
Hello, everyone. Thank you for joining us. Welcome to Veeva Systems' fiscal 2027 first-quarter results conference call.
After today's prepared remarks, we will host a question-and-answer session. (Operator Instructions)
I will now hand the conference over to Gunnar Hansen, Senior Director of Investor Relations. Gunnar, please go ahead.
Good afternoon and welcome to Veeva's fiscal 2027 first-quarter earnings conference call for the quarter ended April 30, 2026.
As a reminder: We posted prepared remarks on Veeva's Investor Relations website, just after 1:00 PM Pacific, today. We hope you have had a chance to read them before the call.
Today's call will be used primarily for Q&A. With me, today, for Q&A are Peter Gassner, our Chief Executive Officer; Paul Shawah, EVP, Strategy; and Brian Van Wagener, our Chief Financial Officer.
During this call, we may make forward-looking statements regarding trends; our strategies; and the anticipated performance of the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
